Bolt Biotherapeutics Files Preliminary Proxy Statement
Ticker: BOLT · Form: DEF 14A · Filed: Apr 15, 2025 · CIK: 1641281
| Field | Detail |
|---|---|
| Company | Bolt Biotherapeutics, Inc. (BOLT) |
| Form Type | DEF 14A |
| Filed Date | Apr 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
Related Tickers: BOLT
TL;DR
Bolt Bio (BOLT) filed its proxy statement for the May 27th meeting. Routine stuff.
AI Summary
Bolt Biotherapeutics, Inc. filed a preliminary proxy statement on April 15, 2025, for its annual meeting on May 27, 2025. The company, previously known as Bolt Therapeutics, Inc., is in the pharmaceutical preparations industry and is incorporated in Delaware. This filing is a routine procedural step for the company's upcoming shareholder meeting.
Why It Matters
This filing indicates that Bolt Biotherapeutics is preparing for its annual shareholder meeting, a key event for corporate governance and strategic decisions.
Risk Assessment
Risk Level: low — This is a routine preliminary proxy statement filing for an upcoming shareholder meeting and does not contain new material financial or operational information.
Key Numbers
- DEF 14A — Filing Type (Indicates a proxy statement filing.)
Key Players & Entities
- Bolt Biotherapeutics, Inc. (company) — Registrant
- Bolt Therapeutics, Inc. (company) — Former company name
- 20250415 (date) — Filing date
- 20250527 (date) — Meeting date
FAQ
What is the purpose of a DEF 14A filing?
A DEF 14A filing, or proxy statement, is used by companies to solicit proxies from shareholders when seeking shareholder approval for corporate actions or to elect directors.
When is the shareholder meeting for Bolt Biotherapeutics?
The shareholder meeting is scheduled for May 27, 2025.
What was Bolt Biotherapeutics' former name?
Bolt Biotherapeutics, Inc. was formerly known as Bolt Therapeutics, Inc.
What is the filing date of this proxy statement?
This preliminary proxy statement was filed on April 15, 2025.
What is the primary business of Bolt Biotherapeutics?
Bolt Biotherapeutics, Inc. is in the Pharmaceutical Preparations industry (SIC code 2834).
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 15, 2025 regarding Bolt Biotherapeutics, Inc. (BOLT).